Related references
Note: Only part of the references are listed.Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)
Hang Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer
Wenfeng Lin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong et al.
DRUG RESISTANCE UPDATES (2020)
The Effect of Diacerein on Type 2 Diabetic Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis
Shizhe Guo et al.
JOURNAL OF DIABETES RESEARCH (2020)
Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
Lehe Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
Amer Alam et al.
SCIENCE (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Unexpected implications of STAT3 acetylation revealed by genetic encoding of acetyl-lysine
Yael Belo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening
Li Wu et al.
BIOFACTORS (2019)
Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell
Norihiko Sugisawa et al.
MOLECULAR PHARMACEUTICS (2018)
Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
Daljit Kaur et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells
Liyan Ji et al.
MOLECULES (2017)
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
Saikat Dewanjee et al.
MOLECULES (2017)
Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein
Hongping Min et al.
PLOS ONE (2017)
Diacerein inhibits the pro-atherogenic & proinflammatory effects of IL-1 on human keratinocytes & endothelial cells
Girish C. Mohan et al.
PLOS ONE (2017)
Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer
R. Bharti et al.
ONCOGENE (2016)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
Rhein triggers apoptosis via induction of endoplasmic reticulum stress, caspase-4 and intracellular calcium in primary human hepatic HL-7702 cells
Arouna KoraMagazi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
Mechanisms of tumor cell resistance to the current targeted-therapy agents
Gholamreza Khamisipour et al.
TUMOR BIOLOGY (2016)
Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives
Qiu-He Chen et al.
CURRENT TRADITIONAL MEDICINE (2016)
ABC transporter research: going strong 40 years on
Frederica L. Theodoulou et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation
Birgit Lohberger et al.
BMC CANCER (2015)
Rhein: A Review of Pharmacological Activities
Yan-Xi Zhou et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases
Yu-Jie Zhang et al.
MOLECULES (2015)
The Functional Influences of Common ABCB1 Genetic Variants on the Inhibition of P-glycoprotein by Antrodia cinnamomea Extracts
Ming-Jyh Sheu et al.
PLOS ONE (2014)
Reduced intracellular drug accumulation in drug-resistant leukemia cells is not only solely due to MDR-mediated efflux but also to decreased
Angela Oliveira Pisco et al.
FRONTIERS IN ONCOLOGY (2014)
Friend or foe: the role of microRNA in chemotherapy resistance
Haoran Li et al.
ACTA PHARMACOLOGICA SINICA (2013)
Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein.
Ricardo J. Ferreira et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
Deactivation of Signal Transducer and Activator of Transcription 3 Reverses Chemotherapeutics Resistance of Leukemia Cells via Down-Regulating P-gp
Xulong Zhang et al.
PLOS ONE (2011)
Assessment of the Evolution of Cancer Treatment Therapies
Manuel Arruebo et al.
Cancers (2011)
Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
J. Rafael Sierra et al.
MOLECULAR CANCER (2010)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Three-dimensional structure of P-glycoprotein - The transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state
MF Rosenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
Considerations in the design and development of transport inhibitors as adjuncts to drug therapy
AH Dantzig et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Communication between multiple drug binding sites on P-glycoprotein
C Martin et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
